Clinical Trial Update: Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating enzalutamide in combination with carboplatin and paclitaxel for stage III-IV or recurrent endometrioid endometrial cancer; results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrioid Endometrial Adenocarcinoma
• Uterine Corpus Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Enzalutamide (enzalutamide)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Uterine Corpus Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-03-19